Research Tracker›Biomarker Atlas›Marker Pages›C18 Acylcarnitine (stearoylcarnitine)

C18 Acylcarnitine (stearoylcarnitine): biomarker evidence

C18 Acylcarnitine (stearoylcarnitine) appears in 1 entry of the OSMF biomarker atlas, covering ME/CFS. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

ME/CFS

Where C18 Acylcarnitine (stearoylcarnitine) is reported

Also listed as: Long-chain acylcarnitine

ConditionDirectionCompared againstAssociated symptomsSource
ME/CFS↑ elevatedhealthy controlsFatty acid metabolism blockJinushi et al. 2023

Frequently asked questions

In which conditions is C18 Acylcarnitine (stearoylcarnitine) altered?

In the OSMF atlas C18 Acylcarnitine (stearoylcarnitine) is reported in ME/CFS. It is elevated in 1 across 1 entries.

Is there a standard clinical test for C18 Acylcarnitine (stearoylcarnitine)?

The atlas entries for C18 Acylcarnitine (stearoylcarnitine) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal C18 Acylcarnitine (stearoylcarnitine) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). C18 Acylcarnitine (stearoylcarnitine) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/c18-acylcarnitine-stearoylcarnitine.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.